Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Fusco

Showing results (41-50 of 80) with videos related to

Pageof 8
Sort By:
The American Journal of Cardiology|January 9, 2019
Usefulness of Circulating Caspase-3 p17 and Caspase-1 p20 Peptides and Cardiac Troponin 1 During Cardioplegia to Gauge Myocardial PreservationMinjung Kim, Michael K Lorinsky, Courtney A Gold, et al.
HIV Medicine|January 28, 2020
Validation of the Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) chronic kidney disease risk score in HIV-infected patients in the USAA M Mills, K L Schulman, J S Fusco, et al.
The American Journal of Medicine|August 9, 2005
Estimating the proportion of patients infected with HIV who will die of comorbid diseasesR Scott Braithwaite, Amy C Justice, Chung-Chou H Chang, et al.
Toxicon : Official Journal of the International Society on Toxinology|March 23, 2022
Traces of Bothrops snake venoms in necrotic muscle preclude myotube formation in vitroAndrea C Van de Velde, Luciano S Fusco, Silvina M Echeverría, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|August 21, 2004
Effect of persistent moderate viremia on disease progression during HIV therapyStephen P Raffanti, Jennifer S Fusco, Beth H Sherrill, et al.
BMC Infectious Diseases|February 14, 2023
Heavily treatment-experienced people living with HIV in the OPERA® cohort: population characteristics and clinical outcomesRicky K Hsu, Jennifer S Fusco, Cassidy E Henegar, et al.
HIV/AIDS (Auckland, N.Z.)|April 22, 2024
Switching to Dolutegravir/Lamivudine Two-Drug Regimen: Durability and Virologic Outcomes by Age, Sex, and Race in Routine US Clinical CareGerald Pierone, Laurence Brunet, Jennifer S Fusco, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|February 15, 2001
Zidovudine and stavudine sequencing in HIV treatment planning: findings from the CHORUS HIV cohortS L Becker, S R Raffanti, N I Hansen, et al.
AIDS (London, England)|October 13, 2020
Incident type 2 diabetes mellitus after initiation of common HIV antiretroviral drugsRicky Hsu, Laurence Brunet, Jennifer S Fusco, et al.
The Journal of Biological Chemistry|May 10, 2000
Identification and molecular characterization of the first alpha -xylosidase from an archaeonM Moracci, B Cobucci Ponzano, A Trincone, et al.
Pageof 8

Showing results (41-50 of 80) with videos related to

Sort By:
Pageof 8
The American Journal of Cardiology|January 9, 2019
Usefulness of Circulating Caspase-3 p17 and Caspase-1 p20 Peptides and Cardiac Troponin 1 During Cardioplegia to Gauge Myocardial PreservationMinjung Kim, Michael K Lorinsky, Courtney A Gold, et al.
HIV Medicine|January 28, 2020
Validation of the Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) chronic kidney disease risk score in HIV-infected patients in the USAA M Mills, K L Schulman, J S Fusco, et al.
The American Journal of Medicine|August 9, 2005
Estimating the proportion of patients infected with HIV who will die of comorbid diseasesR Scott Braithwaite, Amy C Justice, Chung-Chou H Chang, et al.
Toxicon : Official Journal of the International Society on Toxinology|March 23, 2022
Traces of Bothrops snake venoms in necrotic muscle preclude myotube formation in vitroAndrea C Van de Velde, Luciano S Fusco, Silvina M Echeverría, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|August 21, 2004
Effect of persistent moderate viremia on disease progression during HIV therapyStephen P Raffanti, Jennifer S Fusco, Beth H Sherrill, et al.
BMC Infectious Diseases|February 14, 2023
Heavily treatment-experienced people living with HIV in the OPERA® cohort: population characteristics and clinical outcomesRicky K Hsu, Jennifer S Fusco, Cassidy E Henegar, et al.
HIV/AIDS (Auckland, N.Z.)|April 22, 2024
Switching to Dolutegravir/Lamivudine Two-Drug Regimen: Durability and Virologic Outcomes by Age, Sex, and Race in Routine US Clinical CareGerald Pierone, Laurence Brunet, Jennifer S Fusco, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|February 15, 2001
Zidovudine and stavudine sequencing in HIV treatment planning: findings from the CHORUS HIV cohortS L Becker, S R Raffanti, N I Hansen, et al.
AIDS (London, England)|October 13, 2020
Incident type 2 diabetes mellitus after initiation of common HIV antiretroviral drugsRicky Hsu, Laurence Brunet, Jennifer S Fusco, et al.
The Journal of Biological Chemistry|May 10, 2000
Identification and molecular characterization of the first alpha -xylosidase from an archaeonM Moracci, B Cobucci Ponzano, A Trincone, et al.
Pageof 8